吴希振

吴希振 is a declared insider of 羚锐制药 (board member), with filings sourced from SSE / SZSE (CSRC). We count 2 filings; the first trade dates from 6 May 2022 and the latest from 22 February 2023.

Every open-market trade on record is a sale: 2 sales worth €179k. So far in 2023, the count stands at no purchases and 1 sale.

On 22 February 2023 came the latest disclosure, an open-market sale for €171k in 羚锐制药. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.